Medicare Procedure and Patient Information
2012 Medicare Procedure Volume
Volume of procedures performed by Dr. Mark A. Kraus, PHD, MD for Medicare patients.
| doctor visit | 75 |
|---|
(No ratings)
Dr. Mark A. Kraus, PHD, MD is a nephrologist in Murray, UT specializing in nephrology (kidney disease).
Volume of procedures performed by Dr. Mark A. Kraus, PHD, MD for Medicare patients.
| doctor visit | 75 |
|---|
Volume of procedures performed by Dr. Mark A. Kraus, PHD, MD for Medicare patients.
| doctor visit | 93 |
|---|
Information about Medicare patients treated by Dr. Mark A. Kraus, PHD, MD.
| Male | 33 |
|---|---|
| Female | 19 |
| Non-Hispanic White | 0 |
|---|---|
| Black | 34 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 26 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 75 |
|---|---|
| High Cholesterol | 50 |
| Stroke | 0 |
| Ischemic Heart Disease | 31 |
| Depression | 0 |
| Chronic Kidney Disease | 75 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 29 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 58 |
| Dementia | 0 |
| Cancer | 0 |
Volume of procedures performed by Dr. Mark A. Kraus, PHD, MD for Medicare patients.
| doctor visit | 51 |
|---|
Information about Medicare patients treated by Dr. Mark A. Kraus, PHD, MD.
| Male | 31 |
|---|---|
| Female | 12 |
| Non-Hispanic White | 0 |
|---|---|
| Black | 31 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 0 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 22 |
| Hypertension | 75 |
|---|---|
| High Cholesterol | 53 |
| Stroke | 0 |
| Ischemic Heart Disease | 28 |
| Depression | 0 |
| Chronic Kidney Disease | 75 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 28 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 44 |
| Dementia | 0 |
| Cancer | 0 |
Volume of procedures performed by Dr. Mark A. Kraus, PHD, MD for Medicare patients.
| doctor visit | 21 |
|---|
Information about Medicare patients treated by Dr. Mark A. Kraus, PHD, MD.
| From 65 to 74 | 24 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 75 |
|---|---|
| High Cholesterol | 58 |
| Stroke | 0 |
| Ischemic Heart Disease | 0 |
| Depression | 0 |
| Chronic Kidney Disease | 75 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 54 |
| Dementia | 0 |
| Cancer | 0 |
The top procedures that Dr. Mark A. Kraus, PHD, MD treated as a nephrologist in Murray, UT during 2016 were hospital care, inpatient care, vascular procedures and X-rays.
Volume of procedures performed by Dr. Mark A. Kraus, PHD, MD for Medicare patients.
| angioplasty | 28 |
|---|---|
| dialysis access procedures | 29 |
| hospital care | 56 |
| inpatient care | 56 |
| vascular procedures | 42 |
| X-rays | 29 |
Information about Medicare patients treated by Dr. Mark A. Kraus, PHD, MD.
| Male | 62 |
|---|---|
| Female | 67 |
| Non-Hispanic White | 66 |
|---|---|
| Black | 0 |
| Hispanic | 44 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 44 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 53 |
| Hypertension | 75 |
|---|---|
| High Cholesterol | 58 |
| Stroke | 10 |
| Ischemic Heart Disease | 50 |
| Depression | 28 |
| Chronic Kidney Disease | 75 |
| Asthma | 33 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 24 |
| Heart Failure | 58 |
| Chronic Obstructive Pulmonary Disease | 27 |
| Diabetes | 67 |
| Dementia | 12 |
| Cancer | 10 |
The top procedures that Dr. Mark A. Kraus, PHD, MD treated as a nephrologist in Murray, UT during 2017 were hospital care, inpatient care, vascular procedures and catheterization.
Volume of procedures performed by Dr. Mark A. Kraus, PHD, MD for Medicare patients.
| catheterization | 28 |
|---|---|
| device removal | 15 |
| dialysis | 22 |
| doctor visit | 17 |
| hospital care | 315 |
| inpatient care | 315 |
| lab tests | 11 |
| vascular procedures | 70 |
Information about Medicare patients treated by Dr. Mark A. Kraus, PHD, MD.
| Male | 223 |
|---|---|
| Female | 198 |
| Non-Hispanic White | 120 |
|---|---|
| Black | 218 |
| Hispanic | 71 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 126 |
|---|---|
| From 75 to 84 | 91 |
| 85 and over | 32 |
| Less than 65 | 172 |
| Hypertension | 75 |
|---|---|
| High Cholesterol | 60 |
| Stroke | 11 |
| Ischemic Heart Disease | 62 |
| Depression | 32 |
| Chronic Kidney Disease | 75 |
| Asthma | 15 |
| Osteoperosis | 7 |
| Atrial Fibrilation | 15 |
| Heart Failure | 65 |
| Chronic Obstructive Pulmonary Disease | 33 |
| Diabetes | 70 |
| Dementia | 25 |
| Cancer | 8 |
The top procedures that Dr. Mark A. Kraus, PHD, MD treated as a nephrologist in Murray, UT during 2018 were hospital care, inpatient care, vascular procedures and catheterization.
Volume of procedures performed by Dr. Mark A. Kraus, PHD, MD for Medicare patients.
| catheterization | 22 |
|---|---|
| device removal | 17 |
| hospital care | 457 |
| inpatient care | 457 |
| vascular procedures | 114 |
Information about Medicare patients treated by Dr. Mark A. Kraus, PHD, MD.
| Male | 253 |
|---|---|
| Female | 220 |
| Non-Hispanic White | 55 |
|---|---|
| Black | 369 |
| Hispanic | 35 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 146 |
|---|---|
| From 75 to 84 | 102 |
| 85 and over | 53 |
| Less than 65 | 172 |
| Hypertension | 75 |
|---|---|
| High Cholesterol | 71 |
| Stroke | 16 |
| Ischemic Heart Disease | 73 |
| Depression | 27 |
| Chronic Kidney Disease | 75 |
| Asthma | 13 |
| Osteoperosis | 6 |
| Atrial Fibrilation | 20 |
| Heart Failure | 75 |
| Chronic Obstructive Pulmonary Disease | 36 |
| Diabetes | 75 |
| Dementia | 34 |
| Cancer | 12 |
The top procedures that Dr. Mark A. Kraus, PHD, MD treated as a nephrologist in Murray, UT during 2019 were hospital care, inpatient care, vascular procedures and catheterization.
Volume of procedures performed by Dr. Mark A. Kraus, PHD, MD for Medicare patients.
| catheterization | 53 |
|---|---|
| device removal | 26 |
| hospital care | 517 |
| inpatient care | 517 |
| vascular procedures | 110 |
Information about Medicare patients treated by Dr. Mark A. Kraus, PHD, MD.
| Male | 242 |
|---|---|
| Female | 219 |
| Non-Hispanic White | 0 |
|---|---|
| Black | 384 |
| Hispanic | 36 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 132 |
|---|---|
| From 75 to 84 | 113 |
| 85 and over | 49 |
| Less than 65 | 167 |
| Hypertension | 75 |
|---|---|
| High Cholesterol | 72 |
| Stroke | 17 |
| Ischemic Heart Disease | 73 |
| Depression | 31 |
| Chronic Kidney Disease | 75 |
| Asthma | 14 |
| Osteoperosis | 6 |
| Atrial Fibrilation | 22 |
| Heart Failure | 75 |
| Chronic Obstructive Pulmonary Disease | 40 |
| Diabetes | 75 |
| Dementia | 34 |
| Cancer | 12 |
The top procedures that Dr. Mark A. Kraus, PHD, MD treated as a nephrologist in Murray, UT during 2020 were hospital care, inpatient care and vascular procedures.
Volume of procedures performed by Dr. Mark A. Kraus, PHD, MD for Medicare patients.
| doctor visit | 129 |
|---|---|
| hospital care | 34 |
| inpatient care | 34 |
| vascular procedures | 14 |
Information about Medicare patients treated by Dr. Mark A. Kraus, PHD, MD.
| Male | 111 |
|---|---|
| Female | 102 |
| Non-Hispanic White | 92 |
|---|---|
| Black | 95 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 65 |
|---|---|
| From 75 to 84 | 59 |
| 85 and over | 28 |
| Less than 65 | 61 |
| Hypertension | 75 |
|---|---|
| High Cholesterol | 68 |
| Stroke | 15 |
| Ischemic Heart Disease | 64 |
| Depression | 31 |
| Chronic Kidney Disease | 75 |
| Asthma | 12 |
| Osteoperosis | 6 |
| Atrial Fibrilation | 16 |
| Heart Failure | 61 |
| Chronic Obstructive Pulmonary Disease | 19 |
| Diabetes | 65 |
| Dementia | 27 |
| Cancer | 9 |
The top procedures that Dr. Mark A. Kraus, PHD, MD treated as a nephrologist in Murray, UT during 2021 were hospital care and inpatient care.
Volume of procedures performed by Dr. Mark A. Kraus, PHD, MD for Medicare patients.
| doctor visit | 170 |
|---|---|
| hospital care | 118 |
| inpatient care | 118 |
Information about Medicare patients treated by Dr. Mark A. Kraus, PHD, MD.
| Male | 86 |
|---|---|
| Female | 86 |
| Non-Hispanic White | 145 |
|---|---|
| Black | 0 |
| Hispanic | 14 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 76 |
|---|---|
| From 75 to 84 | 43 |
| 85 and over | 27 |
| Less than 65 | 26 |
| Hypertension | 75 |
|---|---|
| High Cholesterol | 56 |
| Stroke | 0 |
| Ischemic Heart Disease | 53 |
| Depression | 35 |
| Chronic Kidney Disease | 75 |
| Asthma | 11 |
| Osteoperosis | 11 |
| Atrial Fibrilation | 15 |
| Heart Failure | 40 |
| Chronic Obstructive Pulmonary Disease | 12 |
| Diabetes | 56 |
| Dementia | 17 |
| Cancer | 7 |
The top procedures that Dr. Mark A. Kraus, PHD, MD treated as a nephrologist in Murray, UT during 2022 were hospital care and inpatient care.
Volume of procedures performed by Dr. Mark A. Kraus, PHD, MD for Medicare patients.
| doctor visit | 174 |
|---|---|
| hospital care | 61 |
| inpatient care | 61 |
Information about Medicare patients treated by Dr. Mark A. Kraus, PHD, MD.
| Male | 85 |
|---|---|
| Female | 88 |
| Non-Hispanic White | 144 |
|---|---|
| Black | 0 |
| Hispanic | 11 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 51 |
|---|---|
| From 75 to 84 | 66 |
| 85 and over | 32 |
| Less than 65 | 24 |
| Hypertension | 75 |
|---|---|
| High Cholesterol | 75 |
| Stroke | 0 |
| Ischemic Heart Disease | 36 |
| Depression | 29 |
| Chronic Kidney Disease | 75 |
| Asthma | 10 |
| Osteoperosis | 14 |
| Atrial Fibrilation | 24 |
| Heart Failure | 35 |
| Chronic Obstructive Pulmonary Disease | 12 |
| Diabetes | 58 |
| Dementia | 9 |
| Cancer | 13 |
The top procedures that Dr. Mark A. Kraus, PHD, MD treated as a nephrologist in Murray, UT during 2023 were hospital care and inpatient care.
Volume of procedures performed by Dr. Mark A. Kraus, PHD, MD for Medicare patients.
| doctor visit | 224 |
|---|---|
| hospital care | 88 |
| inpatient care | 88 |
Information about Medicare patients treated by Dr. Mark A. Kraus, PHD, MD.
| Male | 86 |
|---|---|
| Female | 97 |
| Non-Hispanic White | 151 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 57 |
|---|---|
| From 75 to 84 | 69 |
| 85 and over | 39 |
| Less than 65 | 18 |
| Hypertension | 75 |
|---|---|
| High Cholesterol | 75 |
| Stroke | 0 |
| Ischemic Heart Disease | 37 |
| Depression | 27 |
| Chronic Kidney Disease | 75 |
| Asthma | 16 |
| Osteoperosis | 14 |
| Atrial Fibrilation | 28 |
| Heart Failure | 39 |
| Chronic Obstructive Pulmonary Disease | 12 |
| Diabetes | 56 |
| Dementia | 9 |
| Cancer | 14 |
The top procedures that Dr. Mark A. Kraus, PHD, MD treated as a nephrologist in Murray, UT during 2024 were hospital care and inpatient care.
Volume of procedures performed by Dr. Mark A. Kraus, PHD, MD for Medicare patients.
| doctor visit | 278 |
|---|---|
| hospital care | 76 |
| inpatient care | 76 |
Information about Medicare patients treated by Dr. Mark A. Kraus, PHD, MD.
| Male | 118 |
|---|---|
| Female | 82 |
| Non-Hispanic White | 164 |
|---|---|
| Black | 0 |
| Hispanic | 15 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 64 |
|---|---|
| From 75 to 84 | 87 |
| 85 and over | 21 |
| Less than 65 | 28 |
| Hypertension | 75 |
|---|---|
| High Cholesterol | 75 |
| Stroke | 10 |
| Ischemic Heart Disease | 44 |
| Depression | 33 |
| Chronic Kidney Disease | 75 |
| Asthma | 14 |
| Osteoperosis | 16 |
| Atrial Fibrilation | 29 |
| Heart Failure | 44 |
| Chronic Obstructive Pulmonary Disease | 18 |
| Diabetes | 55 |
| Dementia | 8 |
| Cancer | 11 |
Volume of procedures performed by Dr. Mark A. Kraus, PHD, MD for Medicare patients.
The highest averages for the top procedures that Dr. Mark A. Kraus, PHD, MD treated as a nephrologist in Murray, UT were hospital care, inpatient care, vascular procedures and catheterization.
| angioplasty | 28 |
|---|---|
| catheterization | 34 |
| device removal | 19 |
| dialysis | 22 |
| dialysis access procedures | 29 |
| doctor visit | 123 |
| hospital care | 191 |
| inpatient care | 191 |
| lab tests | 11 |
| vascular procedures | 70 |
| X-rays | 29 |
Information about Medicare patients treated by Dr. Mark A. Kraus, PHD, MD.
| Male | 102 |
|---|---|
| Female | 91 |
| Black / African American | 87 |
|---|---|
| Asian / Pacific Islander | 0 |
| Non-Hispanic White | 72 |
| Native American / Alaskan Native | 0 |
| Hispanic | 17 |
| Other | 0 |
| 75 to 84 | 48 |
|---|---|
| 85 and over | 21 |
| Less than 65 | 57 |
| 65 to 74 | 62 |
The highest averages of the most common conditions of Medicare patients that Dr. Mark A. Kraus, PHD, MD treated were chronic kidney disease, hypertension, high cholesterol and diabetes.
| Hypertension | 69 |
|---|---|
| High Cholesterol | 59 |
| Stroke | 6 |
| Ischemic Heart Disease | 42 |
| Depression | 21 |
| Chronic Kidney Disease | 69 |
| Asthma | 10 |
| Osteoporosis | 6 |
| Heart Failure | 42 |
| Chronic Obstructive Pulmonary Disease | 16 |
| Diabetes | 56 |
| Atrial Fibrillation | 14 |
| Cancer | 7 |
| Dementia | 13 |
He has a state license in Utah.
Licensed In: Utah
Dr. Mark A. Kraus, PHD, MD does not have any reviews yet, be the first to leave a review of Dr. Mark A. Kraus, PHD, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Mark A. Kraus, PHD, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| AstraZeneca Pharmaceuticals LP |
$319
LOKELMA $297 |
$22 |
||||
|---|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. |
$310
SAMSCA $198 |
JYNARQUE $112 |
||||
| Bayer HealthCare Pharmaceuticals Inc. |
$270
Kerendia $270 |
|||||
| Amgen Inc. |
$240
Parsabiv $123 |
Aranesp $18 |
$100 |
|||
| W. L. Gore & Associates, Inc. |
$210
VIABAHN Endoprosthesis with Hep $161 |
VIABAHN Endoprosthesis $37 |
VIABAHN Endoprosthesis with PRO $12 |
|||
| Other |
$968
KRYSTEXXA $245 |
ACTHAR $191 |
VELTASSA $159 |
SOLIRIS $116 |
System One $107 |
Other $150 |
| Food and Beverage | $2,216 |
|---|---|
| Education | $101 |
Dr. Mark A. Kraus, PHD, MD has received 2 research payments totaling $1,801.
Dr. Mark Kraus is an adult nephrology specialist in Murray, UT. He studied medicine at Boston University School of Medicine.